Cancer registry uses cases

1. Variations in cancer care processes:

1.1 Diagnosis broken into metastatic

Complete:

            (1) survival from diagnosis 
            (2) Time from diagnosis to treatment

Next:

            (1) Survival and time to treatment

Future:

            (1) Time from screening to diagnosis 
            (2) Time from symptoms/initial primary care visit to diagnosis

Out of Scope:

            (1) QOC metrics

2. Next: Variations in outcomes of bladder cancer with and w/o liver metastases (Asia)

3. Future: Ascertain uptake of newer tests (genetic,biomarkers)

4. Treatments (drug)

Complete:

            (1) Identify treatment regimens
            (2) Compare tumor registry chemo with identified chemo regimens
            (3) Validate identified chemo regimens against Beacon

Next:

            (1) Compare uptake of newer medications vs. older medications
            (2) Number of medications taken daily by a cancer patient in the 

Future:

            (1) Speed of drug administrations and the risk of allergic reaction/rejection
            (2) Reducing time of administration
            (3) Comparative effectiveness of adhering to the administration rules vs deviations
            (4) Metastatic hormone–sensitive prostate cancer and non-metastatic castration-resistant prostate cancer (Bayer - Christian provided research study)

5. Disease progression

Next:

            (1)	Invite PPRISSM? (Jeremy)

Future:

            (1)	Flatiron PRW?